TOVX logo

Theriva Biologics (TOVX) Accounts Receivable

Annual Accounts Receivable

N/A

December 31, 2023

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

TOVX Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.00 M
TOVX annual accounts receivable is currently at an all-time high

3-Year Low

-
TOVX annual accounts receivable 3-year low is unknown

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
TOVX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 25, 2025
TOVX next annual earnings announcement is scheduled for Mar 25, 2025

OtherTOVXbalance sheetmetrics:

Annual Accounts Payable

$770.00 K
TOVX annual accounts payable is $770.00 thousand

Annual Total Assets

$55.22 M
TOVX annual total assets is $55.22 million

Annual Total Liabilities

$15.52 M
TOVX annual total liabilities is $15.52 million

Annual Cash & Cash Equivalents

$23.18 M
TOVX annual cash & cash equivalents is $23.18 million

Quarterly Accounts Receivable

N/A

September 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

TOVX Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.00 M
TOVX quarterly accounts receivable is currently at an all-time high

3-Year Low

-
TOVX quarterly accounts receivable 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
TOVX previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 25, 2025
TOVX next earnings announcement is scheduled for Mar 25, 2025

OtherTOVXbalance sheetmetrics:

Quarterly Accounts Payable

$756.00 K
TOVX quarterly accounts payable is $756.00 thousand

Quarterly Total Assets

$40.11 M
TOVX quarterly total assets is $40.11 million

Quarterly Total Liabilities

$15.47 M
TOVX quarterly total liabilities is $15.47 million

Quarterly Cash And Cash Equivalents

$16.41 M
TOVX quarterly cash and cash equivalents is $16.41 million

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

TOVX Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

TOVX Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

Theriva Biologics Accounts Receivable History

DateAnnualQuarterly
Sep 2012
-
$122.00 K(-50.2%)
Jun 2012
-
$245.00 K(-44.3%)
Mar 2012
-
$440.00 K(+8.6%)
Dec 2011
$405.00 K(+19.5%)
$405.00 K(-18.2%)
Sep 2011
-
$494.90 K(+11.3%)
Jun 2011
-
$444.70 K(+3.7%)
Mar 2011
-
$428.80 K(+26.5%)
Dec 2010
$339.00 K
$339.00 K(-12.5%)
DateAnnualQuarterly
Sep 2010
-
$387.40 K(+136.2%)
Jun 2010
-
$164.00 K(+83.7%)
Mar 2010
-
$89.30 K(+191.8%)
Dec 2009
$30.60 K(>+9900.0%)
$30.60 K(-68.8%)
Sep 2009
-
$98.20 K(>+9900.0%)
Dec 2008
$0.00(-100.0%)
$0.00(-100.0%)
Jun 2001
-
$761.50 K(-23.8%)
Dec 2000
$1.00 M
$1.00 M

FAQ

  • What is the all time high annual accounts receivable for Theriva Biologics?
  • What is the all time high quarterly accounts receivable for Theriva Biologics?

What is the all time high annual accounts receivable for Theriva Biologics?

Theriva Biologics all-time high annual accounts receivable is $1.00 M

What is the all time high quarterly accounts receivable for Theriva Biologics?

Theriva Biologics all-time high quarterly accounts receivable is $1.00 M